Author(s): Maria-Victoria Mateos, Hareth Nahi, Wojciech Legiec, et. al. EHA Library. Mateos M. Jun 15, 2019; 267406; S823 Abstract: S823 Session topic: 14. Myeloma and other monoclonal gammopathies – Clinical Background DARA IV is approved as a single agent and in combination with standard-of-care regimens for relapsed or refractory multiple myeloma (RRMM)....
Pro zobrazení tohoto obsahu je třeba být přihlášen.